A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

C.A. Rentsch; G.N. Thalmann; I. Lucca; M. Kwiatkowski; G.J. Wirth; R.T. Strebel; D. Engeler; A. Pedrazzini; C. Hüttenbrink; W. Schultze-Seemann; R. Torpai; L. Bubendorf; A. Wicki; B. Roth; P. Bosshard; H. Püschel; D.T. Boll; L. Hefermehl; F. Roghmann; M. Gierth; K. Ribi; S. Schäfer; S. Hayoz

A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

C.A. Rentsch, G.N. Thalmann, I. Lucca, M. Kwiatkowski, G.J. Wirth, R.T. Strebel, D. Engeler, A. Pedrazzini, C. Hüttenbrink, W. Schultze-Seemann, R. Torpai, L. Bubendorf, A. Wicki, B. Roth, P. Bosshard, H. Püschel, D.T. Boll, L. Hefermehl, F. Roghmann, M. GierthK. Ribi, S. Schäfer, S. Hayoz

Careum School of Health

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	195-202
Number of pages	8
Journal	European urology oncology
Volume	5
Issue number	2
Publication status	Published - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Rentsch, C. A., Thalmann, G. N., Lucca, I., Kwiatkowski, M., Wirth, G. J., Strebel, R. T., Engeler, D., Pedrazzini, A., Hüttenbrink, C., Schultze-Seemann, W., Torpai, R., Bubendorf, L., Wicki, A., Roth, B., Bosshard, P., Püschel, H., Boll, D. T., Hefermehl, L., Roghmann, F., ... Hayoz, S. (2022). A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14. European urology oncology, 5(2), 195-202.

@article{7914da1de90f4d1fb7a974f16cf1dd12,

title = "A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Gu{\'e}rin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14",

author = "C.A. Rentsch and G.N. Thalmann and I. Lucca and M. Kwiatkowski and G.J. Wirth and R.T. Strebel and D. Engeler and A. Pedrazzini and C. H{\"u}ttenbrink and W. Schultze-Seemann and R. Torpai and L. Bubendorf and A. Wicki and B. Roth and P. Bosshard and H. P{\"u}schel and D.T. Boll and L. Hefermehl and F. Roghmann and M. Gierth and K. Ribi and S. Sch{\"a}fer and S. Hayoz",

year = "2022",

language = "English",

volume = "5",

pages = "195--202",

journal = "European urology oncology",

number = "2",

}

Rentsch, CA, Thalmann, GN, Lucca, I, Kwiatkowski, M, Wirth, GJ, Strebel, RT, Engeler, D, Pedrazzini, A, Hüttenbrink, C, Schultze-Seemann, W, Torpai, R, Bubendorf, L, Wicki, A, Roth, B, Bosshard, P, Püschel, H, Boll, DT, Hefermehl, L, Roghmann, F, Gierth, M, Ribi, K, Schäfer, S & Hayoz, S 2022, 'A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14', European urology oncology, vol. 5, no. 2, pp. 195-202.

A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14. / Rentsch, C.A.; Thalmann, G.N.; Lucca, I. et al.
In: European urology oncology, Vol. 5, No. 2, 2022, p. 195-202.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

AU - Rentsch, C.A.

AU - Thalmann, G.N.

AU - Lucca, I.

AU - Kwiatkowski, M.

AU - Wirth, G.J.

AU - Strebel, R.T.

AU - Engeler, D.

AU - Pedrazzini, A.

AU - Hüttenbrink, C.

AU - Schultze-Seemann, W.

AU - Torpai, R.

AU - Bubendorf, L.

AU - Wicki, A.

AU - Roth, B.

AU - Bosshard, P.

AU - Püschel, H.

AU - Boll, D.T.

AU - Hefermehl, L.

AU - Roghmann, F.

AU - Gierth, M.

AU - Ribi, K.

AU - Schäfer, S.

AU - Hayoz, S.

PY - 2022

Y1 - 2022

M3 - Article

VL - 5

SP - 195

EP - 202

JO - European urology oncology

JF - European urology oncology

IS - 2

ER -